

WHO WE ARE
The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors and industry service providers who share a common vision of increasing the success.
LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.
OUR PARTNERS






MISSON STATEMENT
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professionals.
LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.

MISSON STATEMENT
The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional.
LSC EVENTS
The meetings also include presentations by emerging companies, providing them with
opportunities to get expert feedback on their technologies and to expand their networks.
LSC MEMBERS
CEOs, Directors, Private Equity and Venture Partners, Angel Investors
Members may have successful track record leading public or private companies.
Baber Ghauri
Healthcare Desperado
Brandy Houser, PhD
Co-Founder at Traverse Biotech
Christopher J. Schaber
PhD – CEO, SOLIGENIX, Inc.
Dan Conley
OnCallCFO for Fundable Teams; Angels
Glenn Whaley
Position: Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Categories: 3. MEMBERS, LSC – New Jersey
Glenn Whaley
Chief Financial Officer at Immunic Therapeutics (Nasdaq:IMUX)
Ira Spector
CEO at SFA Therapeutics, Inc
Jerry Ruddle
CEO at NewIV Medical Corp
Joe Camaratta
President and CEO at Quantaras
John Cavan
Position: Former CFO – Hepion Pharmaceuticals
Categories: 3. MEMBERS, 3. MEMBERS, Boston, MA, LSC – New Jersey
John Cavan
Former CFO – Hepion Pharmaceuticals
WHAT OUR MEMBERS SAY

“The LSC has given me instant access to a number of subject matter experts as well new connections to colleagues up and down the East Coast!”
Mike Webb
President and CEO, CXL Ophthalmics

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.”
Mark Moody PhD
COO, Activate Therapeutics

“What I find unique about the LSC is the multiple new connections I’ve been able to make in different aspects of our ecosystem.”
Mark Tepper PhD
CEO Eumentis Therapeutics

“Joining the LSC was more proof that interacting with peers from the broad life sciences ecosystem is a great vehicle to further enrich my knowledge and stimulate my thinking. I am grateful to the organizers for driving this initiative.”
David Barone
Principal, Boston MedTech Advisors, Inc.